Drug formulations having long and medium chain triglycerides
Details for Australian Patent Application No. 2003277299 (hide)
International Classifications
Event Publications
19 February 2004 Complete Application Filed
Priority application(s): 60/491,050 29.07.03 US; 60/478,430 12.06.03 US; 60/454,812 13.03.03 US; PCT/US03/10533 04.04.03 US
11 November 2004 Application Open to Public Inspection
Published as AU-B-2003277299
29 September 2005 Assignment before Grant
Ulm, Edgar; Mansfield, Robert; Boehm, Marcus ; Conforma Therapeutics Corporation The application has been assigned to Conforma Therapeutics Corporation
3 December 2009 Amendment Made
The nature of the amendment is: Amend the priority details to add under INID (62) 2003226285
10 December 2009 Application Accepted
Published as AU-B-2003277299
8 April 2010 Standard Patent Sealed
27 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003277300-MANAGING RESOURCES FOR IP NETWORKING
2003277298-PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PARKINSON'S DISEASE
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser